These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2256146)

  • 1. Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient.
    Flye MW; Duffy BF; Phelan DL; Ratner LE; Mohanakumar T
    Transplantation; 1990 Dec; 50(6):1051-4. PubMed ID: 2256146
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of immunosuppression on HLA-antibody formation.
    Morales-Buenrostro LE; Castro R; Terasaki PI
    Clin Transpl; 2006; ():227-40. PubMed ID: 18365381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The sensitized rate of preformed antibodies in the candidate of renal transplant recipient].
    Nishigaki F; Yoda K; Takahashi T; Takimoto K; Watanabe T; Shimokawa H; Hirano T; Kataoka Y; Yoshiki T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):859-63. PubMed ID: 3074028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring after transplantation in liver and kidney transplant recipients with anti-donor HLA antibodies.
    Torlone N; Piazza A; Valeri M; Tisone G; Poggi E; Provenzani L; Monaco PI; Adorno D; Casciani CU
    Transplant Proc; 1993 Dec; 25(6):3275-6. PubMed ID: 8266540
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of highly sensitized patients: capitol medical center experience.
    Amante AJ; Ejercito R
    Transplant Proc; 2008 Sep; 40(7):2274-80. PubMed ID: 18790211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destructive and protective effects of antibody on transplants in humans: practical and theoretical considerations.
    Baldwin WM; Paul LC; Claas FH; Daha MR
    Prog Clin Biol Res; 1986; 224():41-67. PubMed ID: 3540995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasmapheresis, immunosuppressive therapy and kidney transplant in a pre-sensitized patient].
    Cuéllar-Cabrera H; Ramírez-Fernández M; Guerra-Rosales MJ; Sánchez-Avila MA
    Bol Med Hosp Infant Mex; 1989 Apr; 46(4):246-50. PubMed ID: 2655653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of HLA antigens and HLA antibodies in the integrated dialysis and transplantation program].
    Erbenová E; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(1):7-39. PubMed ID: 7031866
    [No Abstract]   [Full Text] [Related]  

  • 9. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of the HLA antibodies on allograft acute rejection after cadaveric liver transplantation].
    Chen W; Chen GH; Lu MQ; Yang Y; Cai CJ; Hou BH; Lin Y; Zhang WD; Xiao LL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):774-6. PubMed ID: 16793598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
    J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA antibodies in kidney transplanted patients.
    Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
    Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transplantation in highly sensitized patients.
    Backman U; Fellström B; Frödin L; Sjöberg O; Tufveson G; Wikström B
    Transplant Proc; 1989 Feb; 21(1 Pt 1):762-3. PubMed ID: 2650261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic immunologic pretransplantation monitoring in clinical kidney allotransplantation].
    Sochnev AM; Burshteĭn AM; Shif BA; Samoshenkova LP
    Vestn Akad Med Nauk SSSR; 1988; (7):63-70. PubMed ID: 2973191
    [No Abstract]   [Full Text] [Related]  

  • 15. Can the profile of preformed HLA antibodies in highly sensitized recipients influence the outcome of their kidney transplants?
    Busson M; Bouteiller AM; Prevost P; Raffoux C; Betuel H; Fauchet R; Bignon JD; Guigner F; Calot M; Mercier P
    Transplant Proc; 1987 Oct; 19(5):3746-7. PubMed ID: 3313907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological selection of donors and recipients in renal grafts: antibodies].
    Seignalet J; Mourad G; Mion C
    Nephrologie; 1984; 5(1):33-9. PubMed ID: 6374486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of anti-HLA antibodies prior to transplantation: an effective and successful strategy for highly sensitised renal allograft recipients.
    Taube D; Palmer A; Welsh K; Bewick M; Snowden S; Thick M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):694-5. PubMed ID: 2650226
    [No Abstract]   [Full Text] [Related]  

  • 18. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of lymphocyte-dependent antibodies on human kidney transplants.
    Ting A; Terasaki PI
    Transplantation; 1974 Oct; 18(4):371-3. PubMed ID: 4609299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.